title: Zfra induction of memory anticancer response via a novel immune cell.
abstract: When naive mice receive short Zfra peptides via tail vein injections, they develop lifetime resistance to growth of many cancer xenografts, due to activation of a novel spleen memory Hyal-2+CD3-CD19-Z lymphocyte.In vitroeducation of spleen cells with Zfra activates Z cell for conferring memory anticancer responsein vivo.
authors.affiliation: Institute of Molecular Medicine, National Cheng Kung University , Tainan, Taiwan, ROC.
authors.forename: Wan-Pei
authors.initials: WP
authors.lastname: Su
authors.affiliation: Institute of Molecular Medicine, National Cheng Kung University , Tainan, Taiwan, ROC.
authors.forename: Wan-Jan
authors.initials: WJ
authors.lastname: Wang
authors.affiliation: Department of Cell Biology and Anatomy, National Cheng Kung University , Tainan, Taiwan, ROC.
authors.forename: Chun-I
authors.initials: CI
authors.lastname: Sze
authors.affiliation: Institute of Molecular Medicine, National Cheng Kung University, Tainan, Taiwan, ROC; Center of Infectious Disease and Signaling Research, National Cheng Kung University, Tainan, Taiwan, ROC; Advanced Optoelectronic Technology Center, National Cheng Kung University, Tainan, Taiwan, ROC; Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung, Taiwan, ROC.
authors.forename: Nan-Shan
authors.initials: NS
authors.lastname: Chang
keywords:  Zfra; Hyal-2+ CD3- CD19-; Hyaluronidase Hyal-2; Z lymphocyte; memory anticancer response